Cargando…
Optimizing Dyslipidemia Outcomes
Autores principales: | Lipsy, Robert J., Denke, Margo A., Bottorff, Michael B., Jones, Elyce L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10441196/ http://dx.doi.org/10.18553/jmcp.2003.9.s1.1 |
Ejemplares similares
-
Overview of Pharmacologic Therapy for the Treatment of Dyslipidemia
por: Lipsy, Robert J.
Publicado: (2003) -
Current and Future Directions in MS Management: Key Considerations for Managed Care Pharmacists
por: Lipsy, Robert J., et al.
Publicado: (2009) -
Maintaining Cardiovascular Health in Patients With Mixed Dyslipidemia Optimizing the Management of Hypertriglyceridemia and Non-HDL Cholesterol
por: Ito, Matthew, et al.
Publicado: (2009) -
Anticipating the Future: How the Emergence of Innovative Biologic Agents Impacts Benefit Design, Utilization, and Provider Relations
por: Lipsy, Robert J., et al.
Publicado: (2004) -
Strategies for Optimizing Treatment Outcomes
por: Jones Freeman, Elyce L.
Publicado: (2003)